U.S. stocks moved higher on Tuesday as investors rotated toward healthcare and other value-oriented shares, while technology stocks lagged following their rebound a day earlier. The shift gave the Dow a stronger performance and highlighted changing market leadership as investors assess earnings, valuations and the broader economic outlook.

Healthcare Drives the Market Advance

Healthcare led gains among the S&P 500’s 11 major sector indexes, reaching a record high during Tuesday’s session. Eli Lilly was among the companies supporting the benchmark, while Dow components UnitedHealth, Merck & Co, Johnson & Johnson and Amgen also advanced.

The strength across several major healthcare companies indicates that the sector was not being driven by a single corporate development. Instead, the broad-based advance reflected increased investor interest in companies outside the technology-heavy areas that have dominated much of the recent market narrative.

Moderna also reached its highest level since 2022, adding to the sector’s momentum. The performance illustrates how healthcare stocks have become an important source of market leadership as investors reassess the relative attractiveness of value-oriented companies.

Value Stocks Outperform Growth

The broader rotation was also visible in the performance of smaller companies and investment styles. The Russell 2000 climbed, while value stocks outperformed growth shares. This combination points to a wider movement toward companies whose valuations and business models are less closely tied to the technology and artificial intelligence themes that have recently driven major U.S. indexes.

Technology stocks lagged on Tuesday after rebounding in the previous session. The contrast underscores the market’s shifting balance: investors are continuing to participate in equities, but leadership is becoming more diversified across sectors rather than remaining concentrated in large technology companies.

Corporate Results Add Another Layer

Individual corporate developments also influenced the session. 3M expanded its partnership with Amazon in the data-center business and raised its annual profit forecast, providing support for the industrial company as demand associated with data-center infrastructure continues to develop.

General Motors moved in the opposite direction, with its shares sinking after the automaker signaled rising cost pressures. The contrasting reactions demonstrate the importance of company-specific earnings signals as investors evaluate how businesses are navigating changing input costs and demand conditions.

Market Leadership Enters a New Phase

Tuesday’s trading suggests that investors are looking beyond the technology sector for additional sources of market performance. The combination of healthcare strength, value-stock outperformance and gains among small-cap shares points toward a broader market participation than would be evident from technology performance alone.

For global investors, including those monitoring U.S. markets from Israel, the development is relevant because changes in sector leadership can influence the composition and risk profile of major international equity portfolios. A sustained rotation could also affect how investors assess the balance between growth-oriented technology exposure and more established sectors.

Going forward, attention will remain on corporate earnings, sector leadership and the sustainability of the value rotation. Healthcare’s ability to maintain its record-setting momentum, alongside the performance of technology and small-cap shares, will help determine whether Tuesday’s shift represents a temporary repositioning or a broader change in the structure of U.S. equity-market leadership.